Radiation Oncology

Radiation oncology is a medical specialty that uses radiation therapy to treat cancer. The radiation therapy channel covers all aspects of radiation oncology technology. Radiation therapy includes linear accelerators (LINAC), proton therapy, brachytherapy, image guided radiation therapy (IGRT), focused ultrasound, stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), treatment planning systems and tomotherapy.

T2w images with overlays of lesion boundaries, DWI-derived ADC, DCE-derived 𝐾𝑡𝑟𝑎𝑛𝑠, and CDI𝑠 for six patient cases. (a, b) Two patients with csPCa in the PZ. (c, d) Two patients with csPCa in the TZ. (e) A patient with csPCa in the PZ and insPCa in the TZ. (f) A patient with csPCa in the AS and insPCa in the PZ.
News | Magnetic Resonance Imaging (MRI)
MRI Innovation Makes Cancerous Tissue Light Up and Easier to See

March 28, 2022 — A new form of magnetic resonance imaging (MRI) that makes cancerous tissue glow in medical images could ...

Time March 28, 2022
arrow
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports Advanced Accelerator Applications, a Novartis company, as a long-term supplier for the medical radioisotope component of the newly U.S. Food and Drug Administration (FDA) approved radiotherapeutic, Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (mCRPC) who have been treat
News | Prostate Cancer
ITM Provides n.c.a. Lutetium-177 as Long-Term Supplier for Recently Approved Novel Radiotherapeutic in Metastatic Prostate Cancer

March 28, 2022 — ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, supports ...

Time March 28, 2022
arrow
With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical therapy to treat metastatic castration-resistant prostate cancer (mCRPC)—the Society of Nuclear Medicine and Molecular Imaging (SNMMI) celebrates one of the greatest success stories in nuclear medicine history.
News | Prostate Cancer
SNMMI Applauds FDA Approval of New Metastatic Prostate Cancer Treatment

March 23, 2022 — With today’s U.S. Food and Drug Administration (FDA) approval of 177Lu-PSMA-617—a radiopharmaceutical ...

Time March 23, 2022
arrow
A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer has significantly increased for men 45 and older and coincides with recommendations against routine prostate cancer screenings.
News | Prostate Cancer
Metastatic Prostate Cancer on the Rise Since Decrease in Cancer Screenings

March 23, 2022 — A new study from Keck Medicine of USC finds that the incidence rate of metastatic prostate cancer has ...

Time March 23, 2022
arrow
Analyzing one of the largest databases of patients with cancer and COVID-19 with machine learning models, researchers from Lawrence Livermore National Laboratory and the University of California, San Francisco found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization from COVID-19.
News | Coronavirus (COVID-19)
Machine Learning Model Finds COVID-19 Risks for Cancer Patients

March 22, 2022 — Analyzing one of the largest databases of patients with cancer and COVID-19 with machine learning ...

Time March 22, 2022
arrow
Feature | Radiation Therapy | By Dave Fornell
7 Trends in Radiation Therapy at ASTRO 2021

Here are 7 hot radiation therapy technology trends discussed in sessions and on the expo floor at the American Society ...

Time March 21, 2022
arrow
Addison is the next generation of remote patient monitoring (RPM) technology and offers a solution to the global caregiver crisis and the ongoing COVID-19 challenges by providing health care management outside the doctor’s four walls.
News | Remote Viewing Systems
Next Generation Remote Patient Monitoring Technology Highlighted at HIMSS22

March 18, 2022 — Electronic Caregiver, a national digital health technology and services company, will debut Addison ...

Time March 18, 2022
arrow
Above a certain size, individual brain metastases are often surgically removed with the help of microsurgical resection. In stereotactic radiosurgery (SRS), in contrast, they are usually treated with a single high-dose targeted radiation using cobalt-60-gamma radiation sources.
News | Radiation Therapy
Stereotactic Radiosurgery in Brain Metastases

March 15, 2022 — Above a certain size, individual brain metastases are often surgically removed with the help of ...

Time March 15, 2022
arrow
RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) for all stages of cancer, today announced the close of an $80 million equity financing.
News | Intensity Modulated Radiation Therapy (IMRT)
RefleXion Raises $80 Million to Broaden Cancer Treatment Options

March 14, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...

Time March 14, 2022
arrow
Convergent will use NorthStar’s Ac-225 to radiolabel its lead asset, CONV01-α, a prostate-specific membrane antigen (PSMA)-targeted monoclonal antibody, currently being investigated as a potential ground-breaking treatment for prostate cancer.
News | Prostate Cancer
NorthStar Medical Radioisotopes and Convergent Therapeutics Announce Supply Agreement for Therapeutic Radioisotope Actinium-225 (Ac-225)

March 11, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time March 11, 2022
arrow
COVID-19 vaccine associated myocarditis.
Feature | Radiology Imaging | By Melinda Taschetta-Millane
ITN’s Top 10 for the Month of February

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time March 04, 2022
arrow
Fig. 1. Outline of the workflow from data input, feature extraction, selection, and model construction. Credit: DOI: 10.3233/CBM-210201
News | Artificial Intelligence
Artificial Intelligence and Machine Learning Show Promise in Cancer Diagnosis and Treatment

March 2, 2022 — Artificial intelligence (AI), deep learning (DL), and machine learning (ML) have transformed many ...

Time March 02, 2022
arrow
Penn Medicine Department of Radiation Oncology Amit Maity, MD, PhD (left), James Metz, MD, (middle), Constantinos Koumenis, PhD, (right). Image courtesy of Penn Medicine
News | Radiation Oncology
Penn Medicine Awarded NIH Grant to Study Ultra-fast, High-dose Flash Radiation Therapy for Cancer

March 1, 2022 — With more than $12 million in new funding from the National Institutes of Health (NIH), the Abramson ...

Time March 01, 2022
arrow
Today, the U.S. Food and Drug Administration issued three final guidances to industry regarding cancer clinical trials that parallel the goals of President Biden’s recently announced effort to renew and build upon his 2016 Cancer Moonshot initiative to facilitate continued advancement in cancer prevention, detection, research and patient care.
News | Radiation Oncology
FDA Clinical Trial Guidances Share Biden Administration’s Goals for Advancing Development of Cancer Treatments

March 1, 2022 — Today, the U.S. Food and Drug Administration issued three final guidances to industry regarding cancer ...

Time March 01, 2022
arrow
GammaPod at Allegheny Health Network Cancer Institute
News | Breast Imaging
AHN Cancer Institute Becomes One of Country’s First Centers to Offer Women Groundbreaking GammaPod Treatment

February 25, 2022 — Over her years of faithfully getting annual mammograms, it wasn’t uncommon for Patti Mannarino to ...

Time February 25, 2022
arrow
A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy.
News | Radiation Therapy
Experimental Combinatorial Therapy Eliminates an Incurable Brain Tumor

February 22, 2022 — A study recently accepted for publication in The Journal of Clinical Investigation describes a new ...

Time February 22, 2022
arrow
Short bursts of radiation therapy dramatically enhanced the efficiency of targeting glioblastomas with natural nanoparticle-based immunotherapy, thus suppressing growth of the deadly tumor, inducing anti-tumor immunity and prolonging survival in animal models, a research team at Massachusetts General Hospital (MGH) has discovered.
News | Radiation Therapy
Burst of Radiation and Vesicles-based Immunotherapy Suppress Brain Cancer Growth

February 22, 2022 — Short bursts of radiation therapy dramatically enhanced the efficiency of targeting glioblastomas ...

Time February 22, 2022
arrow
RaySearch has a strong position in the radiotherapy market in Canada with a market share of approximately 25 percent. Charles-Le Moyne hospital has been a RayStation customer since 2018.
News | Treatment Planning
Charles-Le Moyne Hospital in Canada Selects RayStation for Primary Treatment Planning System

February 18, 2022 — RaySearch has a strong position in the radiotherapy market in Canada with a market share of ...

Time February 18, 2022
arrow
18F-rhPSMA-7.3 PET Photo courtesy of Blue Earth Diagnostics. General use: This 18F-rhPSMA-7.3 PET image shows prostate cancer spread beyond the prostate region. Technical use: This 18F-rhPSMA-7.3 PET image shows detection of recurrent prostate cancer in several retroperitoneal lymph nodes, as indicated by the green arrows.
News | Prostate Cancer
Blue Earth Diagnostics Announces Key Results from Phase 3 SPOTLIGHT Study of 18F-rhPSMA-7.3

February 18, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time February 18, 2022
arrow
Benign Prostatic Hyperplasia (BPH) or prostate adenoma seen on MRI examination
News | Prostate Cancer
MRI-guided Radiotherapy Appears to Lead to Fewer Side Effects from Treatment for Prostate Cancer

February 17, 2022 — An interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center ...

Time February 17, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now